FDA Inspection
Pfizer Ireland Pharmaceuticals Unlimited CompanyPfizer Ireland Pharmaceuticals Unlimited Company – FDA Inspection, Jan 26, 2018
Record Details
This FDA Inspection record concerns Pfizer Ireland Pharmaceuticals Unlimited Company, with an inspection on January 26, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 26, 2018
- Product Type
- Drugs
View Company Profile
ID · d0783fea-b14b-46cc-a749-7ce8762f5407
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1044106
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Pfizer Ireland Pharmaceuticals Unlimited Company
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 25, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 17, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 1, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 24, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Ireland Pharmaceuticals Unlimited Company
- FDA Inspection 1274497 - 2024-10-25
- FDA Inspection 1123607 - 2018-08-17
- FDA Inspection 973222 - 2016-04-29
- FDA Inspection 889897 - 2014-08-01
- FDA Inspection 738219 - 2011-06-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.